Apollo Hospitals Chennai and Apollo Clinic Dhanmondi brought together nearly 100 Bangladeshi medical students, postgraduate residents and consultant physicians for an international medical education programme in Dhaka on 1 October, seeking to strengthen specialist knowledge and healthcare collaboration between Bangladesh and India.
The International Continuing Medical Education (CME) programme, jointly organised by Apollo Hospitals Chennai and Apollo Clinic Dhanmondi, whose licensee is JMI Specialized Hospital PLC, was held on Thursday at the clinic’s Dhanmondi premises, featuring scientific sessions on paediatric orthopaedic and urological surgery, the organisers said in a press release.
The programme featured two sessions titled “Current Concepts in Hip Disorders and Malignant Bone Tumors in Children” and “A Paradigm Shift in Pediatric Urology”.
Apollo Hospitals Chennai paediatric urology surgeon Dr Jimmy Shad and paediatric orthopaedic surgeon Dr Sankar R delivered the keynote presentations, sharing their expertise with Bangladeshi participants.
Apollo Clinic Dhanmondi Chief Executive Officer Dr Tamjeed Alam moderated the programme.
The initiative marked another step in the growing partnership between JMI Specialized Hospital PLC and Apollo Hospitals, a South Asian healthcare network operating more than 76 hospitals and over 700 clinics across multiple countries.
The collaboration aims to provide Bangladeshi patients with affordable, international-standard healthcare services locally, reducing the need to travel abroad for treatment while supporting the development of the country’s healthcare sector.
The long-term partnership also seeks to strengthen Bangladesh’s potential as an emerging medical tourism destination.
During the programme, Apollo Clinic Dhanmondi highlighted its clinical performance, reporting that it had served more than 22,000 outpatients and treated over 2,500 inpatient cases.
The clinic also reported completing more than 1,000 surgical procedures and maintaining a surgical site infection rate below 1 per cent, which it cited as evidence of its focus on patient safety and quality care.
